2.9100.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:00Valuation
Current ValuationThe current P/E ratio is 6.47, above the reasonable range, cheaper than 3.83% of the time in the past 1 years, and the industry ranks 6/53, the industry Median 6.94.
6.47xP/E
HK$2.91Stock price
HK$0.45Earnings per share
6.47xP/E
Stock priceHK$2.91Earnings per shareHK$0.45
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 5.93x
- Typical range
- 5.64x–6.23x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.94x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.94x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
03320HKCHINARES PHARMA | 5.90x | 7.23% | HK$28.21B |
01681HKCONSUN PHARMA | 9.90x | 20.92% | HK$13.39B |
02877HKSHINEWAY PHARM | 6.94x | 13.28% | HK$6.43B |
02186HKLUYE PHARMA | 7.70x | 47.27% | HK$6.17B |
02633HKJACOBSON PHARMA | 6.00x | 1.99% | HK$1.81B |
08049HKJILIN CHANGLONG | 6.47x | -- | HK$1.63B |
02348HKDAWNRAYS PHARMA | 5.02x | -- | HK$1.34B |
02161HKJBM HEALTHCARE | 6.15x | 6.78% | HK$1.24B |
00239HKPAK FAH YEOW | 7.45x | -- | HK$737.03M |
00950HKLEE'S PHARM | 4.97x | -- | HK$594.72M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
